Released on = March 15, 2007, 9:32 am

Press Release Author = Lee Biosolutions

Industry = Biotech

Press Release Summary = Lee Biosolutions has announced the production and
availability of very low density lipoprotein (VLDL) from human plasma for purchase
at LeeBio.com.

Press Release Body = March 15, 2007; ST. LOUIS - Lee Biosolutions has announced the
production and availability of very low density lipoprotein (VLDL) from human plasma
for purchase at LeeBio.com.

Very low density lipoprotein contains about 16%-22% cholesterol and high amounts of
triglycerides, which can put people at risk for coronary heart disease. VLDL levels
have also been correlated with accelerated rates of atherosclerosis, and are
elevated in a number of other diseases and metabolic states.

According to Lee Biosolutions President Burton Lee, the company's recent addition of
VLDL to their product line is an extension of their commitment to providing the
latest materials in demand by the research community.

"We constantly keep an ear tuned to our customers and to the international research
community as a whole," Lee said. "This helps us stay on top of the latest trends in
research and assures that we're ready when we're called on to deliver."

Very low density lipoproteins inhibit DNA synthesis in lymphocytes activated by the
nonspecific mitogen concanavalin A (Con A). VLDL is the next step down from
chylomicrons in terms of size and lipid content.
VLDL circulates through the blood giving up triglycerides to fat and muscle tissue
until the VLDL remnants are modified and converted into LDL. The lipoprotein is
produced in the liver.

According to the company, The VLDL donors are of US origin and have been tested and
found to be negative for HbsAg, HCV, HIV-1 & 2, Syphilis and HIV-1 Antigen by
currently approved FDA methods.

Lee Biosolutions is a leader in the biomarker industry, providing the quality
products to clinical labs and researchers around the world, developing tomorrow's
cures. The company has provided the materials used in a number of high profile
biomarker studies. For more information or to place an order, contact Lee
Biosolutions at 314-968-1091, or visit the company's website, www.leebio.com.


Web Site = http://www.leebio.com

Contact Details = Lee Biosolutions Inc.
2924 Mary Avenue
St. Louis, Missouri, USA 63144-2730
Phone: 314-968-1091
Fax: 314-968-9851